Yuliya Chykunova

Yuliya Chykunova

Auto-generated profile, based on publicly available information

Yuliya Chykunova

Malopolska Centre of Biotechnology Virogenetics Laboratory of Virology Jagiellonian University Gronostajowa 7a 30‐387 Krakow Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
VNValeria Napolitano
Valeria Napolitano
ADAgnieszka Dąbrowska
Agnieszka Dąbrowska
KSKenji Schorpp
Kenji Schorpp
AMAndré Mourão
André Mourão
EBEmilia Barreto-Duran
Emilia Barreto-Duran
KPKrzysztof Pyrc
Krzysztof Pyrc
S ummary: The COVID-19 pandemic caused by SARS-CoV-2 has been socially and economically devastating. Despite an unprecedented research effort, effective therapeutics are still missing to limit severe disease and mortality. Using high-throughput screening, we identified acriflavine as a potent papain-like protease (PL pro ) inhibitor. NMR titrations and a co-crystal structure confirm that acriflavine blocks the PL pro catalytic pocket in an unexpected binding mode. We show that the drug inhibits viral replication at nanomolar concentration in cellular models, in vivo in mice and ex vivo in human airway epithelia, with broad range activity against SARS-CoV-2 and other betacoronaviruses. Considering that acriflavine is an inexpensive drug approved in some countries, it may be immediately tested in clinical trials and play an important role during the current pandemic and future outbreaks.

18 April 2025 in ChemMedChem
Verified
Journal Article
Open access
KTKarolina Torzyk-Jurowska
Karolina Torzyk-Jurowska
AŁAgnieszka Łupicka-Słowik
Agnieszka Łupicka-Słowik
RGRenata Grzywa
Renata Grzywa
YCYuliya Chykunova
Yuliya Chykunova
KPKrzysztof Pyrc
Krzysztof Pyrc
MSMarcin Sieńczyk
Marcin Sieńczyk
The O'nyong‐nyong virus (ONNV) is a member of the Alphavirus genus isolated for the first time in 1959 in Gulu (Uganda). The main symptoms of O'nyong‐nyong fever are nonspecific and flu like; a proper diagnosis at the early stage is challenging. Until today, the first ONNV epidemic in 1959–1962 remains one of the largest arbovirus outbreaks ever recorded (over 2 million cases). No specific therapy is available thus far. Capsid protease (CP) is a chymotrypsin‐like serine protease that catalyzes the autoproteolytic maturation of the structural polyprotein and undergoes self‐inactivation upon the release of the mature capsid (C) protein. Despite the discovery of this virus more than 60 years ago, many aspects of CP remain understudied, including substrate specificity. Herein, the structures of the first phosphonic‐type inhibitors and activity‐based probes specific to the ONNV CP are presented.